HELIX BIOSTRUCTURES LLC

HELIX BIOSTRUCTURES LLC specializes in advanced protein production and structural biology services, with deep expertise in the purification, crystallization, and structure determination of complex biomolecules. The company delivers end-to-end solutions for structural characterization, including targeted protein expression, biliverdin reductase A purification, and X-ray crystallography-based structure solution—critical for drug discovery and translational research. Their technical capabilities span recombinant protein engineering, biochemical assay development, and high-resolution structural analysis, enabling precise molecular insights for biomedical applications. A key differentiator is their focus on challenging, low-yield proteins requiring specialized folding and stabilization protocols, positioning them as a niche provider for high-value structural biology projects. The contractor has established a consistent relationship with the Department of Health and Human Services, particularly through the National Center for Advancing Translational Sciences, delivering specialized laboratory services that support mechanistic studies of disease-relevant enzymes. Their work aligns with NIH-funded initiatives focused on protein structure-function relationships and therapeutic target validation, indicating a trusted role in supporting mission-critical biomedical research. Their primary industry focus is in testing laboratories and services under NAICS 541380, where they operate at the intersection of biochemistry and structural biology. They serve the pharmaceutical and biomedical research sectors by providing contract research services that bridge molecular discovery and structural validation, filling a specialized gap in the translational science ecosystem. HELIX BIOSTRUCTURES LLC is a small, privately held entity based in Indianapolis, Indiana, with no federal certifications on record. Their geographic footprint is centered in the Midwest, but their technical services support national research initiatives through federal contracts. The company is positioned as a precision-focused provider for advanced protein characterization, serving government-funded biomedical programs requiring specialized, non-routine laboratory capabilities.